AI English summary of an SEC filing — figures as filed
UnitedHealth Group said on July 31, 2025 that Wayne S. DeVeydt has been appointed its Chief Financial Officer, effective September 2, 2025.
Key points
AI summaryUnitedHealth Group said on July 31, 2025 that Wayne S. DeVeydt has been appointed its Chief Financial Officer, effective September 2, 2025.
The company said John F. Rex, who joined in 2012 and has been Chief Financial Officer since 2016, will become Strategic Advisor to the Chief Executive Officer effective September 2, 2025. It said this is in accordance with his employment contract executed in 2016.
UnitedHealth Group said DeVeydt's employment agreement includes an annual base salary of $1,000,000, an initial target annual bonus of 200% of his annual base salary, and a sign-on bonus of $1,200,000. The company said the sign-on bonus replaces compensation he will be forgoing when joining the company and is subject to clawback if the company terminates him for "cause" or if he resigns without "good reason."
UnitedHealth Group said DeVeydt's annual stock award target has a fair value of $10,000,000, and his pro-rated 2025 annual stock plan award is $3,000,000. The company said there is a separate sign-on stock award with a fair value of $5,000,000, consisting of $2,500,000 in restricted stock units and $2,500,000 in non-qualified stock options, and that the RSUs and NSOs will vest ratably over 4 years.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Wayne S. DeVeydt Appointed Chief Financial Officer
UnitedHealth Group said on July 31, 2025 that Wayne S. DeVeydt has been appointed its Chief Financial Officer, effective September 2, 2025.
Source · Based on the filing body and exhibits
John F. Rex Transitions to Strategic Advisor
The company said John F. Rex, who joined in 2012 and has been Chief Financial Officer since 2016, will become Strategic Advisor to the Chief Executive Officer effective September 2, 2025. It said this is in accordance with his employment contract executed in 2016.
Source · Based on the filing body and exhibits
DeVeydt Employment Agreement: Salary and Bonus Terms
UnitedHealth Group said DeVeydt's employment agreement includes an annual base salary of $1,000,000, an initial target annual bonus of 200% of his annual base salary, and a sign-on bonus of $1,200,000. The company said the sign-on bonus replaces compensation he will be forgoing when joining the company and is subject to clawback if the company terminates him for "cause" or if he resigns without "good reason."
Source · Based on the filing body and exhibits
DeVeydt Stock Compensation Structure and Vesting
UnitedHealth Group said DeVeydt's annual stock award target has a fair value of $10,000,000, and his pro-rated 2025 annual stock plan award is $3,000,000. The company said there is a separate sign-on stock award with a fair value of $5,000,000, consisting of $2,500,000 in restricted stock units and $2,500,000 in non-qualified stock options, and that the RSUs and NSOs will vest ratably over 4 years.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…